EOPTOLINK(SZ:300502) Goldman Sachs·2025-07-16 00:55Investment Rating - The investment rating for Eoptolink is "Buy" with an updated 12-month target price (TP) of Rmb195, increased from Rmb177 [1][10][17]. Core Views - Eoptolink is positioned to benefit from the ramp-up of 400G/800G optical transceivers, driven by key customers' deployments in AI infrastructure expected in 2025 [17]. - The company's strong second-quarter performance, with a net profit of Rmb2.38 billion, represents a 340% year-over-year increase and a 51% quarter-over-quarter increase, exceeding expectations [1][2]. - Eoptolink's valuation is currently at a discount of approximately 20% compared to its larger peer Innolight, which is expected to converge as both companies share similar net profit growth outlooks [2][8]. Summary by Sections Financial Performance - Eoptolink's 2Q net profit was Rmb2.38 billion, significantly above the guidance range of Rmb2.13 billion to Rmb2.63 billion, driven by strong 800G shipments and margin expansion [1]. - Revenue estimates for 2025-2027 have been revised upwards by 6% to 14%, and net profit estimates have been increased by 9% to 20% following the better-than-expected 2Q results [10][11]. Market Position - Eoptolink is a key player in the optical transceiver market in China, with products that include up to 1.6T optical transceivers [17]. - The stock has underperformed relative to peers recently, but the strong profit beat is expected to act as a catalyst for share price recovery [3][2]. Valuation Metrics - The current 12-month forward P/E for Eoptolink is seen as attractive in a historical context, with expectations for further convergence in valuation with Innolight [8][10]. - The updated target price of Rmb195 is based on a 17x multiple of the 2026 estimated earnings [10][17].